Maria Sharapova was given a wild card entry into the U.S. Open, which will mark her first Grand Slam since returning to the tour in April following a 15-month doping suspension.
Sharapova was suspended after testing positive for Meldonium. She appealed her two-year suspension and it was reduced by the Court of arbitration for Sport. The ruling determined that Sharapova was not guilty of doping but was not at fault for taking Meldonium after it was added to the banned substance list by the World Anti-Doping Agency.
Sharapova was denied an entry into the French Open earlier this year after the tournament cited that wild cards given to athletes recovering from injuries and not doping bans.